Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Apr;10(4):599–607.

The catabolism of human γG immunoglobulins of different heavy chain subclasses. III. The catabolism of heavy chain disease proteins and of Fc fragments of myeloma proteins

H L Spiegelberg, B G Fishkin
PMCID: PMC1713114  PMID: 4624553

Abstract

The catabolism of 131I and 125I paired labelled Fc fragments of myeloma proteins and of H chain disease proteins of different heavy chain subclasses was studied in men and monkeys. In contrast to the previously demonstrated catabolic heterogeneity of intact γG immunoglobulins, the Fc fragments and H chain disease proteins of all subclasses tested were catabolized at a similar rate. These data suggest that structures not present on the Fc fragments are responsible for the faster turnover rate of γG3 immunoglobulins and for the differences in half-lives of myeloma proteins within a given subclass.

The catabolic features of the H chain disease proteins differed from those of intact γG. Although the whole body half-lives of the two proteins were similar, the fractional turnover rate of the H chain disease proteins was higher than that of γG, on the average 8% of the intravascular pool/day as compared to 4% for γG. One-half to 1% of the intravascular pool of the H chain disease protein and less than 0·1% of the γG was excreted into the urine. An average of 24% of the H chain disease proteins and 44% of the γG equilibrated into the intravascular compartment.

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ein D., Buell D. N., Fahey J. L. Biosynthetic and structural studies of a heavy chain disease protein. J Clin Invest. 1969 Apr;48(4):785–793. doi: 10.1172/JCI106036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ein D., Waldmann T. A. Metabolic studies of a heavy chain disease protein. J Immunol. 1969 Aug;103(2):345–348. [PubMed] [Google Scholar]
  3. FRANKLIN E. C., LOWENSTEIN J., BIGELOW B., MELTZER M. HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE. Am J Med. 1964 Sep;37:332–350. doi: 10.1016/0002-9343(64)90191-3. [DOI] [PubMed] [Google Scholar]
  4. Frangione B., Milstein C. Partial deletion in the heavy chain disease protein ZUC. Nature. 1969 Nov 8;224(5219):597–599. doi: 10.1038/224597a0. [DOI] [PubMed] [Google Scholar]
  5. GERKE J. R., HANEY T. A., PAGANO J. F., FERRARI A. Automation of the microbiological assay of antibiotics with an autoanalyzer instrumental system. Ann N Y Acad Sci. 1960 Jul 22;87:782–791. doi: 10.1111/j.1749-6632.1960.tb23235.x. [DOI] [PubMed] [Google Scholar]
  6. Grey H. M., Kunkel H. G. Heavy-chain subclasses of human gamma-G-globulin. Peptide and immunochemical relationships. Biochemistry. 1967 Aug;6(8):2326–2334. doi: 10.1021/bi00860a007. [DOI] [PubMed] [Google Scholar]
  7. Ishizaka T., Ishizaka K., Salmon S., Fudenberg H. Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol. 1967 Jul;99(1):82–91. [PubMed] [Google Scholar]
  8. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  9. Morell A., Terry W. D., Waldmann T. A. Metabolic properties of IgG subclasses in man. J Clin Invest. 1970 Apr;49(4):673–680. doi: 10.1172/JCI106279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. OSSERMAN E. F., TAKATSUKI K. PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASE. Medicine (Baltimore) 1963 Nov;42:357–384. [PubMed] [Google Scholar]
  11. Prahl J. W. N- and C-terminal sequences of a heavy chain disease protein and its genetic implications. Nature. 1967 Sep 23;215(5108):1386–1387. doi: 10.1038/2151386a0. [DOI] [PubMed] [Google Scholar]
  12. SPIEGELBERG H. L., WEIGLE W. O. THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med. 1965 Mar 1;121:323–338. doi: 10.1084/jem.121.3.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Spiegelberg H. L., Fishkin B. G., Grey H. M. Catabolism of human gammaG-immunoglobulins of different heavy chain subclasses. I. Catabolism of gammaG-myeloma proteins in man. J Clin Invest. 1968 Oct;47(10):2323–2330. doi: 10.1172/JCI105917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Spiegelberg H. L., Grey H. M. Catabolism of human gamma-G immunoglobulins of different heavy chain subclasses. II. Catabolism of gamma-G myeloma proteins in heterologous species. J Immunol. 1968 Oct;101(4):711–716. [PubMed] [Google Scholar]
  15. Spiegelberg H. L., Weigle W. O. Studies on the catabolism of gamma- G subunits and chains. J Immunol. 1965 Dec;95(6):1034–1040. [PubMed] [Google Scholar]
  16. Spiegelberg H. L., Weigle W. O. The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol. 1968 Aug;101(2):377–380. [PubMed] [Google Scholar]
  17. Terry W. D. Skin-sensitizing activity related to gamma- polypeptide chain characteristics of human IgG. J Immunol. 1965 Dec;95(6):1041–1047. [PubMed] [Google Scholar]
  18. WEIGLE W. O., DIXON F. J. The antibody response of lymph node cells transferred to tolerant recipients. J Immunol. 1959 Jun;82(6):516–519. [PubMed] [Google Scholar]
  19. Waldmann T. A., Strober W. Metabolism of immunoglobulins. Prog Allergy. 1969;13:1–110. doi: 10.1159/000385919. [DOI] [PubMed] [Google Scholar]
  20. Watkins J., Tee D. E. Catabolism of gamma G-globulin and myeloma proteins of the subclasses gamma G1 and gamma G2 in a healthy volunteer. Immunology. 1970 Apr;18(4):537–543. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES